Apontis Pharma AG (APPH)
TG
Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 29.69M | 54.13M | 59.85M | 57.46M |
Total Current Assets | 13.49M | 38.21M | 42.61M | 35.38M |
Cash and Equivalents | 8.06M | 29.84M | 36.35M | 26.82M |
Total Non-Current Assets | 3.46M | 40.71M | 41.57M | 30.26M |
Total Liabilities | 26.23M | 13.42M | 18.29M | 27.2M |
Total Current Liabilities | 4.35M | 3.73M | 6.09M | 11.39M |
Total Non-Current Liabilities | 21.88M | 9.69M | 12.19M | 15.81M |
Total Equity | 3.46M | 40.71M | 41.57M | 30.26M |
Common Equity | 25k | 8.5M | 8.5M | 8.5M |
Retained Earnings | -3.32M | -4.07M | -1.38M | -12.68M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.